[
  {
    "ts": null,
    "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2025 Update",
    "summary": "Davis Selected Advisersâ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn more about the portfolio here.",
    "url": "https://finnhub.io/api/news?id=ad893fda7efff23edddd51ef47b42c28e4a61952dee0627cf6e215442dd95b5d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747166969,
      "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2025 Update",
      "id": 134425396,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1200139358/image_1200139358.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Davis Selected Advisersâ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=ad893fda7efff23edddd51ef47b42c28e4a61952dee0627cf6e215442dd95b5d"
    }
  },
  {
    "ts": null,
    "headline": "Bernstein says market overreacting to Trump order, sees limited new impact on PBMs",
    "summary": "Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) despite a sharp selloff in the sector.",
    "url": "https://finnhub.io/api/news?id=93622bf3095eb121d9bba298cd3738fd0bbbebe10e719d78b2a8ed79a1951500",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747143836,
      "headline": "Bernstein says market overreacting to Trump order, sees limited new impact on PBMs",
      "id": 134409267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) despite a sharp selloff in the sector.",
      "url": "https://finnhub.io/api/news?id=93622bf3095eb121d9bba298cd3738fd0bbbebe10e719d78b2a8ed79a1951500"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
    "summary": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
    "url": "https://finnhub.io/api/news?id=f795aeca1aeaeb8f9da74a50ef82a05537a8f36a77de6c46fe34b91459fb5279",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747130708,
      "headline": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
      "id": 134402287,
      "image": "",
      "related": "CI",
      "source": "DowJones",
      "summary": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
      "url": "https://finnhub.io/api/news?id=f795aeca1aeaeb8f9da74a50ef82a05537a8f36a77de6c46fe34b91459fb5279"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
    "summary": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
    "url": "https://finnhub.io/api/news?id=dcd76ad1652ba0effe07f2bad8e0170e212b7930a1bbca78fcfcf90f73375bee",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747129740,
      "headline": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
      "id": 134402310,
      "image": "",
      "related": "CI",
      "source": "MarketWatch",
      "summary": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
      "url": "https://finnhub.io/api/news?id=dcd76ad1652ba0effe07f2bad8e0170e212b7930a1bbca78fcfcf90f73375bee"
    }
  }
]